Blacksmith Medicines receives European patent for LpxC-targeting antibacterial compounds: San Diego, California Tuesday, November 25, 2025, 16:00 Hrs [IST] Blacksmith Medicines, I ...
20h
Blacksmith Medicines Secures European Patent Allowance for LpxC-Targeting Antibacterial Compounds
Blacksmith Medicines, Inc. (Blacksmith), a leading biopharma dedicated to discovering and developing therapeutics targeting metalloenzymes, today announced that the European Patent Office has issued a ...
But at the United Nations high-level meeting on AMR) in 2024, World Health Organization (WHO) Director-General Tedros Adhanom ...
Iterum Therapeutics plc (Nasdaq: ITRM) (the 'Company” or 'Iterum”), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback